Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART)

Journal of Immunology

Volumn 162, Issue 3, 1999, Pages 1780-1788

  Gray, Clive M ^a,d   Lawrence, Jody ^a   Schapiro, Jonathan M ^a   Altman, John D ^b,c   Winters, Mark A ^a   Crompton, Meg ^a   Loi, Muoi ^a   Kundu, Smriti K ^a   Davis, Mark M ^b   Merigan, Thomas C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

^d NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD8 ANTIGEN; GAG PROTEIN; HLA ANTIGEN CLASS 1; POL PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANTI-HIV AGENTS; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES; GENE PRODUCTS, GAG; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HLA-A ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PHENOTYPE; PROTEIN CONFORMATION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; VIRAL PROTEINS;

EID: 0033083859     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. + T cell homeostasis and function in advanced HIV disease. Science 277:112.
2. Pakker, N. G., D. W. Notermans, R. J. D. Boer, M. T. Roos, F. D. Wolf, A. Hill. J. M. Leonard, S. A. Danner, F. Miedema, and P. T. Schellekens. 1998. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution an proliferation. Nat. Med. 4:208.
3. + T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience. AIDS Res. Hum. Retroviruses 14:561.
4. + repertoire during antiretroviral therapy. Nat. Med. 4:215.
5. Altman, J., P. Moss, P. Goulder, D. Barouch, M. McHeyzer-Williams, J. Bell, A. McMichael, and M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94.
6. Kalams, S., R, Johnson, and A. Trocha. 1994. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited repertoire. J. Exp. Med. 179:1261.
7. Kalams, S., R. Johnson, M. Dynan, K. Hartman, T. Harrer, E. Harrer, A. Trocha, W. Blattner, S. Buchbinder, and B. Walker. 1996. T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant. J. Exp. Med. 183:1669.
8. Lalvani, A., T. Dong, O. Graham, A. A. Patham, H. Newell, A. V. Hill, A. McMichael, and S. Rowland-Jones. 1997. Optimization of a peptide-based protocol employing IL-7 for in vitro stimulation of human cytotoxic T lymphocyte precursors. J. Immunol. Methods 210:65.
9. Ogg, G. S., X. Jin, S. Bonhoeffer, P. R. Dunbar, M. A. Nowak, S. Monard, J. P. Segal, Y. Cao, S. L. Rowland-Jones, V. Cerundolo, et al. 1998. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279:2103.
10. Kundu, S., E. Engleman, C. Benike, M Shapiro, M. Dupuis, W. V. Schooten, M. Eibl, and T. Merigan. 1998. A pilot clinical trial of HIV antigen-pulsed allogeneic and autologous dendritic cell therapy in HIV-infected patients. AIDS Res. Hum. Retrovirus 14:551.
11. + T-cell counts in HIV-infected patients. Ann. Intern. Med. 124:1039.
12. + T cells: a reevalualion of bystander activation during viral infection. Immunity 8:177.
13. Klenerman, P., and R. M. Zinkernagel. 1997. What can we learn about human immunodeficiency virus infection from a study of lymphocytic choriomeningitis virus? Immunol. Rev. 159:5.
14. Collins, K. L., B. K. Chen, S. A. Kalams, B. D. Walker, and D. Baltimore. 1998. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391:397.
15. Tsomides, T. 1994. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J. Exp. Med. 180:1283.
16. Yang, O. 1996. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytoloxic T lymphocytes. J. Virol. 70:5799.
17. Brander, C., W. Pichler, and G. Corradin. 1995. Identification of HIV protein-derived cytotoxic T lymphocyte (CTL) epitopes for their possible use as a synthetic vaccine. Clin. Exp. J. Immunol. 101:107.
18. McMichael, A., and R. Phillips. 1997. Escape of human immunodeficiency virus from immune control. Annu. Rev. Immunol. 15:271.
19. Goulder, P., A. Sewell, D. Lallo, D. Price, J. Whelan, J. Evans, G. Taylor, G. Luzzi, P. Giangrande, R. Phillips, and A. McMichael. 1997. Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte antigen (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation. J. Exp. Med. 185:1423.
20. Ruppert, J., J Sidney, E. Celis, R. Kubo, H. Grey, and A. Sette. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74:1.
21. Brander, C., K. E. Hartman, A. K. Trocha, N. G. Jones, R. P. Johnson, B. Korber, P. Wentworth, S. P. Buchbinder, S. Wolinsky, B. D. Walker, and S. A. Kalams. 1998. Lack of strong immune selection pressure by the immunodominant. HLA-A*0201-restricted cytoloxic T lymphocyte response in chronic human immunodeficiency virus-1 infection. J. Clin. Invest. 101:2559.
22. + cytotoxic T cells express CD38 and HLA-DR antigens. J. Immunol. 150:3070.
23. + lymphocytes in human immunodeficiency virus-specific cytotoxic activity. J. Virol. 70:2022.
24. + T cells in HIV disease. Adv. Exp. Med. Biol. 371B:1023.
25. + T cells. Clin. Immunol. Immunopathol. 81:200.
26. Pantaleo, G., H. Soudeyns, J. Demarest, M. Vaccarezza, C. Graziosi, S. Paolucci, M. Daucher, O. Cohen, F. Denis, W. Biddison, R. Sekaly, and A. Fauci. 1997. Accumulation of human immunodeficiency virus-specific cytotoxic T lymphocytes away from the predominant site of virus replication during primary infection. Eur J. Immunol. 27:3166.
27. Wong, J., H. F. Gunthard, D. V. Havlir, Z.-Q. Zhang, A. T. Haase, C. C. Ignacio, S. Kwok, E. Emino, and D. D. Richman. 1997. Reduction in HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc. Natl. Acad. Sci. USA 94:12574.
28. Pantaleo, G. 1997. How immune-based interventions can change HIV therapy. Nat. Med. 3:483.
29. + cell turnover. Nature 375:194.
30. + cell turnover. Nature 375:193.
31. Zinkernagel, R. M., S. Ehl, P. Aichele, S. Oehen, T. Kundig, and H. Hengartner. 1997. Antigen localization regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol. Rev. 156: 199.
32. Kundig, T. 1996. On the role of antigen in maintaining cytotoxic T-cell memory. Proc. Natl. Acad. Sci. USA 93:9716.
33. + T-cell memory. CD45R subsets, and the persistence of antigen: a unifying concept. Immunol. Today 19: 60.
34. Lau, L., B. Jamieson, T. Somasundaram, and R. Ahmed. 1994. Cytotoxic T-cell memory without antigen. Nature 369:648.
35. Bevan, M. J., and T. J. Braciale. 1995. Why can't cyloloxic T cells handle HIV? Proc. Natl. Acad. Sci. USA 92:5765.
36. Feinberg, M., and A. McLean. 1997. AIDS: decline and fall of immune surveillance. Curr. Biol. 7:R136.